Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00372658 · ClinicalTrials.gov registry record · Phase 2
Intracervical Block Versus Placebo to Assess Pain Control During Hysterosalpingogram
A Phase 2 study, sponsored by 59th Medical Wing.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT00372658 is a Phase 2 study that has completed, run by 59th Medical Wing. The registered enrollment target is 120 participants.
The verdict
NCT00372658, a Phase 2 study, has completed, sponsored by 59th Medical Wing.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy of 1% lidocaine intracervical block to placebo for pain control during the performance of a hysterosalpingogram (HSG). We hypothesized that an intracervical block would decrease pain during a hysterosalpingogram.
Interventions
- DRUG 1% Lidocaine intracervical injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2002-07 |
| Est. Completion | 2004-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00372658
The ClinicalTrials.gov registry entry for NCT00372658 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 59th Medical Wing, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 1% Lidocaine intracervical injection is the first listed.
NCT00372658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00372658 about?
NCT00372658 is a clinical study titled "Intracervical Block Versus Placebo to Assess Pain Control During Hysterosalpingogram". The purpose of this study is to compare the efficacy of 1% lidocaine intracervical block to placebo for pain control during the performance of a hysterosalpingogram (HSG). We hypothesized that an intracervical block would decrease pain during a hysterosalpingogram.
What is the current status of trial NCT00372658?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2002-07. Estimated completion is 2004-10.
What interventions are being tested in trial NCT00372658?
The interventions under investigation include: 1% Lidocaine intracervical injection (DRUG).
Who is sponsoring clinical trial NCT00372658?
This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.